JP2021536482A5 - - Google Patents

Info

Publication number
JP2021536482A5
JP2021536482A5 JP2021512830A JP2021512830A JP2021536482A5 JP 2021536482 A5 JP2021536482 A5 JP 2021536482A5 JP 2021512830 A JP2021512830 A JP 2021512830A JP 2021512830 A JP2021512830 A JP 2021512830A JP 2021536482 A5 JP2021536482 A5 JP 2021536482A5
Authority
JP
Japan
Prior art keywords
ring
optionally substituted
salt
compound
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021512830A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021536482A (ja
JP7448527B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2019/035233 external-priority patent/WO2020050409A1/en
Publication of JP2021536482A publication Critical patent/JP2021536482A/ja
Publication of JP2021536482A5 publication Critical patent/JP2021536482A5/ja
Application granted granted Critical
Publication of JP7448527B2 publication Critical patent/JP7448527B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021512830A 2018-09-07 2019-09-06 ヘテロ環式化合物 Active JP7448527B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2018167488 2018-09-07
JP2018167488 2018-09-07
PCT/JP2019/035233 WO2020050409A1 (en) 2018-09-07 2019-09-06 Heterocyclic compound

Publications (3)

Publication Number Publication Date
JP2021536482A JP2021536482A (ja) 2021-12-27
JP2021536482A5 true JP2021536482A5 (enExample) 2022-09-14
JP7448527B2 JP7448527B2 (ja) 2024-03-12

Family

ID=68063002

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021512830A Active JP7448527B2 (ja) 2018-09-07 2019-09-06 ヘテロ環式化合物

Country Status (12)

Country Link
US (2) US11932657B2 (enExample)
EP (1) EP3847176A1 (enExample)
JP (1) JP7448527B2 (enExample)
KR (1) KR102810086B1 (enExample)
CN (1) CN112654627A (enExample)
AU (2) AU2019335968B2 (enExample)
CA (1) CA3109610A1 (enExample)
EA (1) EA202190654A1 (enExample)
IL (1) IL280821B2 (enExample)
SG (1) SG11202101963XA (enExample)
TW (1) TWI854995B (enExample)
WO (1) WO2020050409A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102810086B1 (ko) 2018-09-07 2025-05-21 오츠카 세이야쿠 가부시키가이샤 헤테로시클릭 화합물
WO2021117733A1 (en) 2019-12-09 2021-06-17 Otsuka Pharmaceutical Co., Ltd. Acrylamide compounds
KR20220153595A (ko) 2020-02-26 2022-11-18 재규어 테라퓨틱스 피티이 리미티드 AhR 신호전달의 조절에 유용한 피리도피리미딘 유도체
CN114181212B (zh) * 2020-09-15 2023-06-06 山东轩竹医药科技有限公司 哒嗪酮类AhR抑制剂
CN115215720B (zh) * 2021-04-19 2023-08-22 中国科学院化学研究所 含薁单元的石墨烯纳米片段分子—薁并玉红省及其合成方法与应用
WO2022228399A1 (zh) * 2021-04-27 2022-11-03 山东轩竹医药科技有限公司 三并环类usp1抑制剂及其用途
WO2023033741A1 (en) * 2021-09-02 2023-03-09 Jaguahr Therapeutics Pte Ltd Compounds useful in modulation of ahr signalling
WO2023033742A1 (en) * 2021-09-02 2023-03-09 Jaguahr Therapeutics Pte Ltd Compounds useful in modulation of ahr signalling
US20250129092A1 (en) * 2021-09-02 2025-04-24 Jaguahr Therapeutics Pte Ltd Compounds useful in modulation of ahr signalling
CN119948035A (zh) 2022-10-03 2025-05-06 捷豹治疗有限公司 可用于调节AhR信号传导的化合物
CN120187915A (zh) * 2022-10-29 2025-06-20 松本油脂制药株式会社 弹性纤维用处理剂及其利用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20100362A1 (es) 2008-10-30 2010-05-27 Irm Llc Derivados de purina que expanden las celulas madre hematopoyeticas
AU2011343712B2 (en) * 2010-12-16 2015-09-17 Genentech, Inc. Tricyclic PI3k inhibitor compounds and methods of use
WO2014138485A1 (en) 2013-03-08 2014-09-12 Irm Llc Ex vivo production of platelets from hematopoietic stem cells and the product thereof
HK1248762A1 (zh) 2015-06-16 2018-10-19 国立大学法人京都大学 高功能性血小板的制造方法
FI3612030T3 (fi) 2017-04-21 2026-03-20 Pahr Therapeutics Inc Ahr:n indoliestäjiä ja niiden käyttötapoja
WO2019167973A1 (en) 2018-03-01 2019-09-06 Kyoto University Cell cycle progression inhibitor
KR102810086B1 (ko) 2018-09-07 2025-05-21 오츠카 세이야쿠 가부시키가이샤 헤테로시클릭 화합물
WO2021117733A1 (en) 2019-12-09 2021-06-17 Otsuka Pharmaceutical Co., Ltd. Acrylamide compounds
JP2022188761A (ja) 2021-06-09 2022-12-21 大塚製薬株式会社 窒素原子含有複素環化合物を用いる血小板産生方法

Similar Documents

Publication Publication Date Title
CN100369899C (zh) 具有抗癌活性的取代的吲唑
JP2013505948A5 (enExample)
JP2009523146A5 (enExample)
JP2015143283A5 (enExample)
JP2008523069A5 (enExample)
JP2004529161A5 (enExample)
JP2013539795A5 (enExample)
JP2008517983A5 (enExample)
AR036041A1 (es) Compuestos aromaticos heterociclicos sustituidos con quinuclidina y composiciones farmaceuticas que los contienen
EA201071012A1 (ru) Производные азетидинов, способ их получения и применение их в терапии
JP2021523168A5 (enExample)
CO5650234A2 (es) Antagonistas duales nk1/nk3´para tratar la esquizofrenia
JP2019522628A5 (enExample)
JP2019514879A (ja) アシルスルホンアミドNaV1.7阻害剤
JP2022548820A (ja) プロテインキナーゼ阻害剤としてのイソキノリン誘導体
CA2521399A1 (en) Di-aryl substituted pyrrole modulators of metabotropic glutamate receptor-5
ES2571741T3 (es) Bencimidazoles sustituidos como inhibidores de Mps-1 quinasa
JP2016535040A5 (enExample)
JPWO2021107065A5 (enExample)
JP2022534902A5 (enExample)
JP2012528839A5 (enExample)
JP2008525400A5 (enExample)
PE20090325A1 (es) Nuevos compuestos ligandos del receptor de la adenosina a3
MX2012008147A (es) Derivados de pirrazolopiridina.
PL149903B1 (en) Method of obtaining novel derivatives of 1h,3h-pyrol/1,2-c/thiazole